SecBot SecBot
Insider Cluster (3 insiders) ·Filed Oct 16, 2026

CRSP

CRISPR Therapeutics AG
NEUTRAL
Impact 3/10
Horizondays Processed9d 18h ago
Insider cluster: 3 insiders, $1.0M total
Actionable Insight • Neutral

The CEO and GC's sales are tied to derivative exercises (cashless exercise-and-sell), which are routine and not directional. Director Simeon's $720K sale is the only purely discretionary open-market sale, but at 0.02% of market cap it is immaterial. No bearish signal here — monitor next quarterly update for pipeline progress (CTX001) and cash runway.

DirectionNeutral
Confidencehigh
Horizondays
Latest settled — T+1d ⚠ clustered
CRSP ▼ -0.32% at T+1d
NEUTRAL call -0.32% · α vs SPY -0.66% · entry $50.04 → $49.88
Next anchor: T+5d due 3d ago
Latest observation: T+4 -4.50% FF3 residual α
Entry = T+0 close
Oct 16, 2026
via day close
T+1d
-0.32%
call -0.32% · α -0.66%
$49.88
settled 7d ago
T+5d
Pending
due 3d ago
T+20d
Pending
in 18d
T+60d
Pending
in 3mo

Price Chart

Loading chart...

Executive Summary

Three CRSP insiders, including the CEO and a director, sold a combined ~$973K in open-market sales over a two-day window. The CEO's sale followed a same-day derivative exercise at $0, indicating a cashless exercise-and-sell pattern rather than a purely discretionary bearish signal. The director's $720K sale is the largest and most notable, but the total is modest relative to CRSP's ~$3.5B market cap (~0.03%), making this a low-concern event.

Key Financial Metrics

Direction
selling
Total Value
$973.0K
Insiders
3

Key Facts

  • Director George Simeon sold 14,500 shares at ~$49.63 for $720K on 2026-10-14.
  • CEO Samarth Kulkarni sold 4,098 shares at ~$49.26 for $202K on 2026-10-14, following a same-day derivative exercise of 8,333 shares at $0.
  • General Counsel James Kasinger sold 1,040 shares at ~$49.26 for $51K on 2026-10-14, following a same-day derivative exercise of 2,113 shares at $0.
  • Total open-market sales: ~$973K, representing ~0.03% of CRSP's estimated $3.5B market cap.
  • No 10b5-1 plan indication provided for any of the sales.

Financial Impact

~$973K in insider open-market sales, ~0.03% of market cap — trivial relative to company size.

dilution

Risk Factors

  • Insider selling pattern could escalate if more director-level sales appear in subsequent filings.
  • No 10b5-1 plan disclosed — future sales without plans could raise scrutiny.

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-CRSP-1792187177670
14 reports for CRSP
Performance horizon
75% Hit rate @ T+20 3 of 4 directional calls Went positive at some point 5 of 6 best @ T+20▲ +8.92%Sep 24, 2026
Filters
Rows
Reports for CRSP — sortable, filterable
TypeNow
Oct 20, 2026
5d ago
Insider Cluster
BEARISH ★ 5/10
$50.50awaiting T+20—$49.62 (+1.74%)
Oct 19, 2026
6d ago
8-K
NEUTRAL ★ 3/10
$49.88awaiting T+20—$49.62 (−0.52%)
Oct 16, 2026
9d ago
Insider Cluster
NEUTRAL ★ 3/10
$50.04awaiting T+20—$49.62 (−0.84%)
Oct 16, 2026
9d ago
Insider Cluster
BEARISH ★ 4/10
$50.04awaiting T+20—$49.62 (+0.84%)
Oct 15, 2026
10d ago
Insider Cluster
NEUTRAL ★ 3/10
$49.25awaiting T+20—$49.62 (+0.75%)
Oct 14, 2026
11d ago
144
NEUTRAL ★ 2/10
$51.52awaiting T+20—$49.62 (−3.69%)
Oct 6, 2026
19d ago
144
NEUTRAL ★ 2/10
$52.35awaiting T+20—$49.62 (−5.21%)
Sep 24, 2026
4w ago
Insider Cluster
BEARISH ★ 5/10
$54.23 $49.39▲ +8.92%▲ +7.45%$49.62 (+8.50%)
Aug 28, 2026
8w ago
Press Release
BULLISH ★ 7/10
$57.72 $54.23▼ −6.05%▼ −6.56%$49.62 (−14.03%)
Aug 3, 2026
11w ago
Press Release
BULLISH ★ 6/10
$53.07 $56.82▲ +7.07%▲ +8.30%$49.62 (−6.50%)
Showing 10 of 14

US Market Status

Market Open — Closes in 3h 56m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 16, 2026